Acute Myeloid Leukemia Clinical Trials in Marseille
12 recruitingMarseille, France
Showing 1–12 of 12 trials
Recruiting
Phase 2
Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE
Acute Myeloid Leukemia
Institut Paoli-Calmettes35 enrolled1 locationNCT06055621
Recruiting
Phase 2
De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients
Acute Myeloid Leukemia
Institut Paoli-Calmettes50 enrolled1 locationNCT06557421
Recruiting
Phase 2
Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT
Acute Myeloid Leukemia in Remission
Nantes University Hospital302 enrolled23 locationsNCT05917405
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemias
Janssen Research & Development, LLC400 enrolled101 locationsNCT04811560
Recruiting
Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia (AML)
Acute Leukemia French Association5,000 enrolled30 locationsNCT04777916
Recruiting
Phase 1Phase 2
AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia, RefractoryMyelodysplastic Syndrome/Acute Myeloid Leukemia
AB Science78 enrolled10 locationsNCT05211570
Recruiting
Phase 1
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
Myelodysplastic SyndromesRelapsed or Refractory Acute Myeloid Leukemia (AML)Untreated AML+1 more
Institut de Recherches Internationales Servier291 enrolled30 locationsNCT02074839
Recruiting
Phase 2
Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
Acute Myeloid Leukemia
Ryvu Therapeutics SA98 enrolled37 locationsNCT06191263
Recruiting
Phase 2Phase 3
Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR
Acute Myeloid Leukemia (AML)
University Hospital, Angers3,100 enrolled56 locationsNCT02416388
Recruiting
Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies
Acute Myeloid LeukemiaGenetic Predisposition to Disease
Assistance Publique - Hôpitaux de Paris500 enrolled28 locationsNCT05772559
Recruiting
Phase 1Phase 2
Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris64 enrolled13 locationsNCT05580861
Recruiting
Phase 2
CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics
Acute Myeloid Leukemia
Centre Hospitalier Universitaire de Nice210 enrolled30 locationsNCT05260528